Johnson & Johnson(JNJ)
Drug Manufacturers - General · New Brunswick, NJ
$267.51+0.31 (+0.11%)
Delayed quote: Sep 16, 2026, 2:55 PM EDT
Drug Manufacturers - General · New Brunswick, NJ
Delayed quote: Sep 16, 2026, 2:55 PM EDT
Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 24.76% is in line with its 5-year average of 25.10%, near the low end of its 5-year range (17.37%–54.95%).
As of the fiscal period ended Sunday, June 28, 2026. 14.10% below its 12-month average of 28.82%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-28): 24.76%.
RETURN ON EQUITY (ROE)
24.76%
RETURN ON EQUITY (ROE) AVG TTM
28.82%
RETURN ON EQUITY (ROE) AVG 3Y
33.68%
RETURN ON EQUITY (ROE) AVG 5Y
25.10%
RETURN ON EQUITY (ROE) AVG 10Y
24.61%
RETURN ON EQUITY (ROE) AVG 15Y
22.53%
RETURN ON EQUITY (ROE) AVG 20Y
23.40%
CURRENT VS TTM AVG
-14.10%
CURRENT VS 3Y AVG
-26.49%
CURRENT VS 5Y AVG
-1.38%
CURRENT VS 10Y AVG
+0.59%
CURRENT VS 15Y AVG
+9.90%
CURRENT VS 20Y AVG
+5.82%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+90.30%
vs the sector median at left
Johnson & Johnson
Market Cap
$644.66B
Return on Equity (ROE)
24.76%
TTM Avg
28.82%
3Y Avg
33.68%
5Y Avg
25.10%
Market Cap
$156.11B
Return on Equity (ROE)
5.09%
TTM Avg
9.04%
3Y Avg
13.32%
5Y Avg
16.07%
Market Cap
$355.46B
Return on Equity (ROE)
7.57%
TTM Avg
35.83%
3Y Avg
26.05%
5Y Avg
27.71%
Market Cap
$462.99B
Return on Equity (ROE)
N/A
TTM Avg
-0.29%
3Y Avg
28.74%
5Y Avg
37.53%
Market Cap
$1.07T
Return on Equity (ROE)
78.84%
TTM Avg
76.20%
3Y Avg
64.92%
5Y Avg
71.94%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | $644.66B | 24.76% | 28.82% | 33.68% | 25.10% |
| Pfizer Inc. (PFE)vs › | $156.11B | 5.09% | 9.04% | 13.32% | 16.07% |
| Merck & Co., Inc. (MRK)vs › | $355.46B | 7.57% | 35.83% | 26.05% | 27.71% |
| AbbVie Inc. (ABBV)vs › | $462.99B | N/A | -0.29% | 28.74% | 37.53% |
| Eli Lilly and Company (LLY)vs › | $1.07T | 78.84% | 76.20% | 64.92% | 71.94% |
| Bristol-Myers Squibb Company (BMY)vs › | $129.65B | 41.59% | -8.30% | 7.76% | 4.45% |
ROE
24.8%
ROA
10.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-28 | 24.76% |
| 2026-03-29 | 25.92% |
| 2025-12-28 | 32.87% |
| 2025-09-28 | 31.69% |
| 2025-06-29 | 28.88% |
| 2025-03-30 | 27.92% |
| 2024-12-29 | 19.68% |
| 2024-09-29 | 20.93% |
| 2024-06-30 | 53.14% |
| 2024-03-31 | 54.95% |
| 2023-12-31 | 51.11% |
| 2023-10-01 | 48.61% |
| 2023-07-02 | 17.37% |
| 2023-04-02 | 17.95% |
| 2022-12-31 | 23.36% |
| 2022-10-02 | 25.68% |
| 2022-07-03 | 24.05% |
| 2022-04-03 | 26.54% |
| 2021-12-31 | 28.20% |
| 2021-10-03 | 25.44% |
| 2021-07-04 | 25.53% |
| 2021-04-04 | 22.96% |
| 2020-12-31 | 23.25% |
| 2020-09-27 | 26.35% |
| 2020-06-28 | 24.11% |
| 2020-03-29 | 28.01% |
| 2019-12-31 | 25.42% |
| 2019-09-29 | 24.31% |
| 2019-06-30 | 26.87% |
| 2019-03-31 | 24.90% |
| 2018-12-31 | 25.60% |
| 2018-09-30 | 2.39% |
| 2018-07-01 | 2.18% |
| 2018-04-01 | 1.97% |
| 2017-12-31 | 2.16% |
| 2017-10-01 | 21.39% |
| 2017-07-02 | 22.71% |
| 2017-04-02 | 23.46% |
| 2016-12-31 | 23.49% |
| 2016-10-02 | 21.91% |
| 2016-07-03 | 20.73% |
| 2016-04-03 | 21.40% |
| 2015-12-31 | 21.66% |
| 2015-09-27 | 20.56% |
| 2015-06-28 | 22.64% |
| 2015-03-29 | 23.45% |
| 2014-12-31 | 23.40% |
| 2014-09-28 | 22.61% |
| 2014-06-29 | 19.93% |
| 2014-03-30 | 19.67% |
| 2013-12-31 | 18.68% |
| 2013-09-29 | 18.45% |
| 2013-06-30 | 18.47% |
| 2013-03-31 | 15.62% |
| 2012-12-31 | 16.74% |
| 2012-09-30 | 13.34% |
| 2012-07-01 | 14.46% |
| 2012-04-01 | 16.47% |
| 2011-12-31 | 16.94% |
| 2011-10-02 | 18.52% |
| 2011-07-03 | 18.69% |
| 2011-04-03 | 20.52% |
| 2010-12-31 | 23.57% |
| 2010-10-03 | 23.73% |
| 2010-07-04 | 25.59% |
| 2010-04-04 | 25.11% |
| 2009-12-31 | 24.25% |
| 2009-09-27 | 25.35% |
| 2009-06-28 | 27.55% |
| 2009-03-29 | 29.36% |
| 2008-12-31 | 30.46% |
| 2008-09-28 | 27.57% |
| 2008-06-29 | 25.51% |
| 2008-03-30 | 25.43% |
| 2007-12-31 | 24.41% |
| 2007-09-30 | 23.80% |
| 2007-07-01 | 24.54% |
| 2007-04-01 | 25.22% |
| 2006-12-31 | 28.11% |
| 2006-10-01 | 27.28% |
| 2006-07-02 | 26.62% |
| 2006-04-02 | 25.81% |
| 2005-12-31 | 26.22% |
| 2005-10-02 | 24.92% |
| 2005-07-03 | 25.55% |
| 2005-04-03 | 26.31% |
| 2004-12-31 | 26.75% |
| 2004-09-26 | 28.99% |
| 2004-06-27 | 29.51% |
| 2004-03-28 | 26.74% |
| 2003-12-31 | 26.79% |
| 2003-09-28 | 26.17% |
| 2003-06-29 | 26.14% |